European Commission logo
français français
CORDIS - Résultats de la recherche de l’UE
CORDIS
Contenu archivé le 2024-05-23

European action on anticoagulation (eaa): cost-effectiveness of computer-assisted dosage (eaa computer-dosage)

Objectif

Oral Anticoagulant Treatment (OAT) is being used on an increasing scale in EU countries but steps are required to improve poor success of doctors in dosage as, even at specialised centres, patients are only maintained within therapeutic targets for about 50% of the time. Bleeding and thrombosis complications are associated with time "out of control" and labile control, both shown by an EC funded pilot study to be reduced by computer-dosage. A wide-ranging study sufficiently large to provide clinical end-points will be undertaken, to assess the extent to which computerised OAT dosage reduces thrombosis and haemorrhagic complications and is cost-effective. Cost-effectiveness from reduction of clinical complications and demands on medical manpower and administrative savings will be evaluated and the potential for increased provision of OAT within existing resources. Previously funded EC control materials will check conformity to WHO laboratory standards and treatment levels.

Champ scientifique

Programme(s)

Thème(s)

Appel à propositions

Data not available

Régime de financement

CSC - Cost-sharing contracts

Coordinateur

UNIVERSITY OF MANCHESTER
Contribution de l’UE
Aucune donnée
Adresse
Oxford Road
MANCHESTER
Royaume-Uni

Voir sur la carte
Liens
Coût total
Aucune donnée

Participants (41)

Partager cette page

Télécharger

Dernière mise à jour: 12 Avril 2005

Mon livret

Permalink: https://cordis.europa.eu/project/id/QLG4-CT-2001-02175/fr

European Union, 2024